We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy (ARCTIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00827411
Recruitment Status : Completed
First Posted : January 22, 2009
Last Update Posted : April 12, 2013
Sponsor:
Collaborators:
Allies in Cardiovascular Trials Initiatives and Organized
Institut National de la Santé Et de la Recherche Médicale, France
Sanofi
Bristol-Myers Squibb
Medtronic
Cordis Corporation
Fondation de France
Diagnostica Stago
Boston Scientific Corporation
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2012
  Study Completion Date : January 2013
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):